Humanoid Robot Startup Funding 2025-2026

In our humanoid robotics market deck, you will find everything you need to understand the market
SUMMARY
We analyzed every publicly disclosed equity round raised by pure-play humanoid robotics companies between August 2025 and September 2026, using a $300K minimum deal size and a greater-than-80% pure-play threshold. The resulting sample contains 22 deals across 16 unique companies and approximately $5.292B of disclosed capital.
Fundraising in the humanoid robotics market is dominated by very large financings. The median round is $148M and the average is $240.55M, while 19 of 22 deals are strictly above $50M.
Capital is highly concentrated. The largest deal accounts for 18.90% of all disclosed capital, the top 3 reach 45.73%, the top 5 reach 58.24%, and the top 10 account for 77.00%.
The scale of the market almost disappears when large rounds are removed. Excluding rounds above $50M leaves only $105M, meaning roughly 98% of disclosed capital sits around or above the $50M financing level.
Deal flow averages 1.57 rounds per calendar month across August 2025 through September 2026, while average capital raised per month is approximately $378M. The monthly pattern is highly uneven, including zero qualifying deals in August 2025, June 2026, and September 1–2, 2026.
General Purpose Humanoids leads the humanoid robotics market with 12 deals and approximately $3.461B raised. It captures 65.39% of capital against 54.55% of deals, giving the category a 1.20x capital-share-to-deal-share ratio.
Asia-Pacific dominates company and deal activity, producing 16 of 22 rounds and approximately $3.324B. North America contributes only 3 deals but $1.685B, creating a 2.33x capital-share-to-deal-share ratio.
Among rounds with a classifiable stage, the humanoid robotics market leans toward scaling rather than formation. Late-stage rounds represent approximately 59.6% of classified capital, versus 40.4% for Seed, Series A, and Series B combined.
Follow-on financing overwhelmingly dominates the dataset. Nineteen of the 22 qualifying deals are follow-ons, while only Generative Bionics, the Beijing Innovation Center of Humanoid Robotics, and XPENG Robotics are classified as first financings.
Repeat investors are concentrated around a relatively small group of strategic and financial backers. IDG Capital and HongShan/HSG each appear in at least three qualifying rounds, while CAS Investment, CICC-linked vehicles, BAIC-linked vehicles, and E-Town-linked capital also recur.

This market map, featured in our humanoid robotics market deck, highlights top companies and startups in the humanoid robotics market
What are all the funding deals in the humanoid robotics market from August 2025 to September 2026?
The table below lists every qualifying disclosed equity round raised by pure-play humanoid robotics companies between August 2025 and September 2026. We define the humanoid robotics market as robots with a human-like torso and two arms or hands designed to perform tasks in human-built environments, including bipedal or wheeled humanoid platforms, mobile manipulators marketed as humanoids, and integrated robot systems combining hardware with onboard autonomy.
We exclude non-manipulating mobile robots, traditional industrial arms in fixed cells, exoskeletons and prosthetics, entertainment animatronics unless they are sold as task-performing robots, and broader embodied-AI companies that do not satisfy the greater-than-80% pure-play requirement. For a wider view of the sector, see our Humanoid Robotics market report.
| Company | What they do | Category | Date | Stage | Deal size | Region | Main investors |
|---|---|---|---|---|---|---|---|
| X Square Robot | General-purpose embodied-AI humanoid robots, including the Quanta platform, for manipulation in human environments | General Purpose Humanoids | Sep 2025 | Unknown | $140M | Asia-Pacific | Alibaba Cloud; CAS Investment; China Development Bank Capital; HongShan Capital Group |
| Figure | Autonomous general-purpose humanoid robots and the Helix embodied-AI stack for commercial and household work | General Purpose Humanoids | Sep 2025 | Series C | $1,000M+ | North America | Parkway Venture Capital; Brookfield; NVIDIA; Macquarie Capital; Intel Capital; Salesforce; Qualcomm Ventures |
| Leju Robotics | Humanoid robots for industrial manufacturing and other commercial deployment environments | Industrial Labor Robots | Oct 2025 | Growth Equity | $200M+ | Asia-Pacific | CITIC Goldstone; Shenzhen Investment Holdings |
| Noetix Robotics | Compact and full-size humanoid robots, including lower-cost consumer-oriented humanoid platforms | Consumer Home Robots | Oct 2025 | Unknown | $41M | Asia-Pacific | Vertex Ventures; FG Venture; CRRC Beijing Transformation and Upgrading Fund; OR Capital; Everpine Capital |
| Booster Robotics | Bipedal humanoid hardware and software platforms for developers, research, education, and commercial deployment | General Purpose Humanoids | Nov 2025 | Unknown | $14M+ | Asia-Pacific | IDG Capital; E-Town Capital; Source Code Capital; InnoAngel Fund; Shenzhen Capital Group |
| Flexion | Reinforcement-learning intelligence stack designed specifically to act as the brain for humanoid robots | Humanoid AI Platforms | Nov 2025 | Series A | $50M | Europe | DST Global Partners; NVentures; redalpine; Prosus Ventures; Moonfire |
| ROBOTERA | Full-size and wheeled humanoid robots with embodied intelligence for commercial and industrial applications | General Purpose Humanoids | Nov 2025 | Series A | $140M | Asia-Pacific | Geely Capital; BAIC Capital; Beijing government-backed AI and robotics funds |
| Generative Bionics | Intelligent humanoid robots aimed primarily at industrial-scale work and human-machine collaboration | Industrial Labor Robots | Dec 2025 | Unknown | $81.6M | Europe | CDP Venture Capital; Tether Investments; AMD Ventures; industrial investors |
| Galbot | General-purpose humanoid robots and proprietary embodied-AI models for manufacturing, logistics, retail, and healthcare | General Purpose Humanoids | Dec 2025 | Unknown | $300M+ | Asia-Pacific | Investor group disclosed by company |
| Zhejiang Humanoid Robot Innovation Center | General-purpose humanoid robots intended for mass production across multiple working environments | General Purpose Humanoids | Jan 2026 | Series A | $64.7M | Asia-Pacific | SUPCON; China Merchants Innovation and Technology; Lenovo Capital; Zhejiang Province Venture Capital Group; FG Venture |
| Beijing Innovation Center of Humanoid Robotics / X-Humanoid | Developer of the Tiangong series of full-size humanoid robots and associated embodied intelligence | General Purpose Humanoids | Feb 2026 | Unknown | $100M+ | Asia-Pacific | Beijing Robotics Industry Development Investment Fund; E-Town Capital; TH Capital; Baidu-backed participation |
| Apptronik | Developer of Apollo, a general-purpose humanoid robot initially targeted at manufacturing and industrial work | Industrial Labor Robots | Feb 2026 | Series A | $520M | North America | B Capital; Google; Mercedes-Benz; PEAK6; AT&T Ventures; John Deere; Qatar Investment Authority |
| Galaxea AI | Embodied-intelligence humanoid and mobile-manipulation robots, including foldable humanoid systems | General Purpose Humanoids | Feb 2026 | Series B | $144M | Asia-Pacific | Jinding Capital; BAIC Group Industrial Investment; Hone Capital; Cathay Capital; Meituan Dragonball; Capital Today |
| Noetix Robotics | Consumer-oriented and general-purpose humanoid robots focused on lowering humanoid hardware costs | Consumer Home Robots | Mar 2026 | Series B | $145.9M | Asia-Pacific | Chendao Capital; CAS Investment; Beijing Jingguosheng Investment Fund; Unity Ventures |
| Galbot | General-purpose humanoid robots and proprietary embodied-AI models for manufacturing, logistics, retail, and healthcare | General Purpose Humanoids | Mar 2026 | Unknown | $362M | Asia-Pacific | National AI Industry Investment Fund; Sinopec; CITIC-linked entities; Bank of China; SAIC-linked capital; E-Town |
| Sunday Robotics | Developer of Memo, a household humanoid robot designed for chores such as laundry and clearing tables | Consumer Home Robots | Mar 2026 | Series B | $165M | North America | Coatue Management; Tiger Global; Benchmark; Bain Capital Ventures |
| ROBOTERA | General-purpose and wheeled humanoid robots for industrial and commercial work | General Purpose Humanoids | Mar 2026 | Growth Equity | $146M | Asia-Pacific | Gaocheng Capital; Singtel Innov8; Woori Venture Partners; CICC Porsche Fund; CDH Venture and Growth Capital |
| Booster Robotics | Bipedal humanoid robot hardware, embodied-AI software, and development platforms | General Purpose Humanoids | Apr 2026 | Unknown | $150M | Asia-Pacific | Beijing High-Tech Industries Investment Fund; Jingguosheng Fund; Huakong Fund; existing shareholders |
| X Square Robot | General-purpose and household humanoid robots powered by proprietary physical-AI models | Consumer Home Robots | Apr 2026 | Series B | $276M | Asia-Pacific | Xiaomi; HongShan; ByteDance; Meituan; Alibaba |
| ROBOTERA | Humanoid robots including the M7 for parcel induction, sorting, and other logistics workloads | Logistics Work Robots | May 2026 | Growth Equity | $200M+ | Asia-Pacific | SF Group; HSG; IDG Capital; Hillhouse Investment; CICC Capital; ICBC Capital; China Unicom-affiliated funds |
| Humanoid | Industrial humanoid robots, including wheeled platforms, combined with the proprietary KinetIQ physical-AI stack | Industrial Labor Robots | Jul 2026 | Series A | $152M | Europe | Prime Movers Lab; Schaeffler; Bosch; Fubon Financial Holding Venture Capital; Aglaé Ventures |
| XPENG Robotics / Dogotix | Separately financed robotics business developing the IRON general-purpose humanoid robot and Physical-AI stack | General Purpose Humanoids | Aug 2026 | Growth Equity | $900M+ | Asia-Pacific | IDG Capital; Gaorong Ventures; Tencent; Alibaba; XPENG-related subscriptions |

In our humanoid robotics market deck, we identify pain points entrepreneurs should prioritize
OUR METHODOLOGY TO BUILD THIS TRACKER
We built this humanoid robotics funding tracker by reviewing publicly disclosed equity rounds announced between August 2025 and September 2026. A company counts as pure-play when more than 80% of its activity is dedicated to humanoid robot platforms, humanoid-specific intelligence software, or humanoid-specific components that fall inside the defined market scope.
We applied four core filters. We only included equity financings, only counted disclosed rounds of $300K or more, only retained companies meeting the greater-than-80% pure-play requirement, and required every qualifying round to be supported by a direct company announcement, press release, or tier-1 media report with the source URL retained in the underlying dataset.
Debt, grants, acquisitions, proposed or rumored rounds, secondary-only transactions, and financings without a disclosed equity amount are excluded. Broad embodied-AI companies spanning humanoids, quadrupeds, vehicles, fixed arms, or other robot forms were also removed when humanoid robotics could not defensibly account for more than 80% of the business.
Where a company described a financing as “more than,” “over,” or “nearly” a headline amount, we use the disclosed headline figure as a conservative analytical value. The resulting approximately $5.292B total should therefore be read as a lower-bound dataset rather than as false precision.
The final dataset contains 22 qualifying deals across 16 unique companies. Public-only funding trackers cannot capture private financings that were never announced, so the dataset should be treated as a strict pure-play baseline rather than a literal census of every humanoid robotics investment worldwide.
How active has fundraising been in the humanoid robotics market?
As of September 2026, fundraising in the humanoid robotics market has been highly active in dollar terms but relatively concentrated in deal count. Over the past 12 months, the dataset contains 22 disclosed equity rounds totaling approximately $5.292B across 16 unique companies.
The humanoid robotics market averages 1.57 disclosed deals per calendar month and approximately $378M of capital per month. Those averages are not representative of a typical month because financing arrives in large, irregular bursts.
Monthly deal activity ranged from zero qualifying rounds in August 2025 and June 2026 to four rounds in March 2026. February through April 2026 alone produced nine qualifying deals, showing how quickly activity can cluster.
Fundraising activity is therefore better understood through deal size, repeat financing, and concentration than through monthly averages alone. For more detail on the companies driving this activity, see our humanoid robotics funding report.
How concentrated has fundraising been in the humanoid robotics market?
As of September 2026, fundraising in the humanoid robotics market is heavily concentrated in a small number of transactions. Over the past 12 months, the largest round represents 18.90% of disclosed capital, the top 3 account for 45.73%, and the top 5 reach 58.24%.
The top 10 rounds account for 77.00% of the approximately $5.292B total. That means the lower half of the deal ranking contributes only a minority of measured dollars even though those transactions still represent meaningful company activity.
Figure's $1B-plus Series C is the largest single financing, while XPENG Robotics contributes another approximately $900M. Apptronik's $520M extension provides a third major anchor, so aggregate funding can move sharply when only a few companies raise.
This concentration makes total capital a useful scale indicator but a poor standalone measure of ecosystem breadth. Deal count, median round size, and unique-company count provide essential context.
How much of the humanoid robotics funding signal is driven by outliers?
As of September 2026, the funding signal in the humanoid robotics market is strongly driven by very large rounds, but the effect extends well beyond one isolated outlier. Over the past 12 months, 19 of 22 qualifying rounds are strictly above $50M and 16 are strictly above $100M.
Removing every round above $50M leaves only $105M of the approximately $5.292B dataset. In other words, roughly 98% of measured capital is associated with financings around or above the $50M scale.
The average round is $240.55M, compared with a median of $148M. The 1.63x gap confirms a right-tailed distribution, but the $148M median also shows that large checks are normal in the visible dataset rather than purely the result of Figure.
This makes humanoid robotics look more like capital-intensive frontier infrastructure than conventional venture formation. Manufacturing capacity, hardware iteration, deployment fleets, and data acquisition can require financing levels that would be considered late-stage in many software markets.

This chart, featured in our humanoid robotics market deck, shows how Agility Robotics is capturing share in humanoid robotics
Is the humanoid robotics market broad with many targets, or narrow with few fundable companies?
As of September 2026, the humanoid robotics market is narrow in terms of the number of repeatedly fundable companies. Over the past 12 months, 22 qualifying financings were raised by only 16 unique companies, with several leading platforms appearing more than once.
ROBOTERA raised three qualifying rounds during the period, while Galbot, Noetix Robotics, Booster Robotics, and X Square Robot each raised twice. Repeat financing therefore represents a meaningful share of visible market activity.
Only three deals are classified as first financings, while 19 are follow-ons. This suggests investors are allocating most new capital to teams that have already passed an earlier technical or financing selection point.
The market is broader in Asia-Pacific than elsewhere, but even there capital repeatedly returns to a recognizable group of platforms. The relevant opportunity set is therefore larger than a handful of companies, but much smaller than aggregate physical-AI funding figures might imply.
Is humanoid robotics mostly an early-stage formation market or a late-stage scaling market?
As of September 2026, the humanoid robotics market increasingly behaves like a scaling market rather than a conventional early-stage formation market. Over the past 12 months, late-stage capital represents approximately $2.446B, or 46.22% of total disclosed capital, versus approximately $1.658B for Seed, Series A, and Series B combined.
Unknown-stage rounds contribute another approximately $1.189B, or 22.46% of the dataset. Once those unknown rounds are removed, late-stage financings represent approximately 59.6% of classifiable capital versus 40.4% for early-stage rounds.
Stage labels are unusually weak signals of financial maturity in this market. Five Series A rounds account for approximately $926.7M, and Apptronik alone raised a $520M Series A-X extension.
The more useful maturity indicators are manufacturing capacity, field deployment, customer involvement, follow-on cadence, and cumulative capital raised. We examine those scaling signals further in our analysis of the humanoid robotics market.
Which categories attract the most investor attention in humanoid robotics?
As of September 2026, General Purpose Humanoids attract the most investor attention in the humanoid robotics market. Over the past 12 months, the category accounts for 12 of 22 qualifying deals and approximately $3.461B, equal to 65.39% of disclosed capital.
Industrial Labor Robots rank second with 4 deals and approximately $953.6M, or 18.02% of capital. Consumer Home Robots also produced 4 deals but raised a lower $627.9M, equal to 11.86% of the total.
Logistics Work Robots has only one formally specialized financing, ROBOTERA's $200M-plus May round. That deal count understates logistics as a deployment environment because several general-purpose and industrial humanoid companies also target warehouses and material handling.
Humanoid AI Platforms contribute one $50M round, while no Actuation Component Supplier passed the strict pure-play screen. The dataset therefore tilts strongly toward integrated robot companies rather than standalone component or software layers.

This chart, featured in our humanoid robotics market deck, illustrates yearly funding for humanoid robotics startups
Which categories attract disproportionately large checks in the humanoid robotics market?
As of September 2026, General Purpose Humanoids attract the most disproportionately large checks among multi-deal categories in the humanoid robotics market. Over the past 12 months, the category captures 65.39% of capital against 54.55% of deals, producing a 1.20x capital-share-to-deal-share ratio.
Industrial Labor Robots sit almost exactly at parity, with 18.02% of capital and 18.18% of deals for a 0.99x ratio. Their $238.40M average round remains large, but the category does not capture more capital than its activity share would predict.
Consumer Home Robots show the opposite pattern. They represent 18.18% of deals but only 11.86% of capital, giving the category a 0.65x ratio despite a still-substantial $155.45M median round.
Humanoid AI Platforms have the lowest ratio at 0.21x, while the single Logistics Work Robots deal produces a 0.83x ratio. For a deeper look at how capital is distributed across the sector, see our humanoid robotics category analysis.
Which geographies matter most for fundraising in the humanoid robotics market?
As of September 2026, Asia-Pacific matters most for deal activity while North America matters disproportionately for capital intensity in the humanoid robotics market. Over the past 12 months, Asia-Pacific produced 16 of 22 deals and approximately $3.324B, or 62.80% of disclosed capital.
North America generated only 3 deals but approximately $1.685B, giving the region 31.84% of all capital from just 13.64% of deal activity. Its capital-share-to-deal-share ratio is 2.33x.
The contrast is even clearer in deal size. North America's average qualifying round is approximately $561.67M and its median is $520M, compared with a $207.73M average and $145.95M median in Asia-Pacific.
Europe contributes 3 deals and $283.6M, or 5.36% of capital. For more context on regional leaders and financing patterns, see our full humanoid robotics market report.
Is the humanoid robotics opportunity set broad or concentrated in one hub?
As of September 2026, the humanoid robotics opportunity set is concentrated in two major hubs rather than one. Over the past 12 months, Asia-Pacific and North America together account for 86.36% of qualifying deals and 94.64% of disclosed capital.
Asia-Pacific provides the broader company base, with 16 deals across numerous Chinese humanoid platforms. The region repeatedly finances companies at roughly $100M to $300M scale rather than concentrating almost all capital in one company.
North America has the opposite structure. Only Figure, Apptronik, and Sunday Robotics appear in the qualifying dataset, but Figure and Apptronik alone contribute approximately $1.52B.
Europe remains a meaningful but much smaller third hub, with Flexion, Generative Bionics, and Humanoid. Latin America, the Middle East, and Africa contribute no qualifying rounds in the strict dataset.

This chart, featured in our humanoid robotics market deck, compares the main business model options for humanoid robot manufacturers
Is humanoid robotics a market of small experiments or scaled financings?
As of September 2026, the humanoid robotics market is overwhelmingly a market of scaled financings rather than small experiments. Over the past 12 months, 20 of 22 deals are $50M or larger when $50M itself is included, and the median qualifying round is $148M.
Only one disclosed deal falls between $5M and $20M, and only one sits between $20M and below $50M. There are no qualifying rounds below $5M.
Using a strict greater-than threshold, 19 of 22 rounds exceed $50M and 16 exceed $100M. If $100M exactly is included as a megaround, the $100M-plus count rises to 17.
The financing structure therefore looks less like prototype-stage venture activity and more like a race to fund factories, supply chains, data collection, and deployments. For additional market context, see our report on humanoid robotics funding and scale.
Who are the investors that appear the most in humanoid robotics fundraising?
As of September 2026, IDG Capital and HongShan Capital Group or HSG are the most visible repeat investors in the humanoid robotics market. Over the past 12 months, each appears in at least three qualifying financings based strictly on named participation.
IDG Capital appears in Booster Robotics, ROBOTERA, and XPENG Robotics financings. HongShan or HSG appears in X Square Robot's September 2025 and April 2026 rounds and in ROBOTERA's May 2026 financing when the firm's current branding is consolidated.
CAS Investment, CICC-linked vehicles, BAIC-linked vehicles, and E-Town-linked capital each appear in at least two qualifying deals. Multiple Beijing government-backed robotics and AI funds also recur, although their legal vehicles differ enough that they should not be collapsed into a single investor.
Alibaba-linked capital appears repeatedly as well, but Alibaba Cloud, Alibaba strategic investments, and other group vehicles are not automatically identical investing entities. Investor frequency should therefore be treated as a minimum-count analysis rather than a perfectly normalized ownership map.
Round announcements also rarely disclose the exact check written by each participant. Investor rankings measure participation frequency, not the amount of capital personally committed by each investor.

This chart, featured in our humanoid robotics market deck, shows the revenue mix across customer segments in the humanoid robotics market
INSIGHTS
The insights below are drawn from the 22 qualifying equity financings identified in the humanoid robotics market between August 2025 and September 2026. They focus on reusable signals for interpreting future funding announcements rather than simply repeating the deal table.
The humanoid robotics market has crossed into a financing regime where megarounds are normal rather than exceptional. A future $100M round should therefore not automatically be interpreted as proof of category leadership.
The $148M median matters more than the $240.55M average. It shows that unusually large checks appear throughout the distribution, not only in Figure-sized outliers.
Removing rounds above $50M leaves only $105M of measured capital. The visible market is therefore financing scale-building much more aggressively than experimentation.
Stage labels have unusually weak explanatory power in humanoid robotics. A Series A can exceed $500M, so manufacturing progress and deployment readiness are more useful maturity indicators than the letter attached to the round.
Repeat financing cadence is a stronger signal than a single large valuation. Companies able to raise again within months demonstrate continued investor access while manufacturing and deployment costs are rising.
ROBOTERA and Galbot illustrate this particularly clearly. Repeated nine-figure rounds within short intervals suggest that capital itself has become a competitive input into production capacity, customer acquisition, and data generation.
General-purpose humanoids receive a capital premium because broad task optionality increases the number of markets investors can underwrite. That optionality helps explain the category's 1.20x capital-share-to-deal-share ratio.
Consumer humanoids receive meaningful validation but less capital per financing attempt. The category's 0.65x ratio implies investors are still pricing household deployment as a less proven scaling thesis.
Industrial humanoids sit close to parity between capital share and deal share. Factory deployment appears to function as the market's baseline commercialization case rather than as either a premium or discounted niche.
Logistics is more important than its single specialized deal suggests. General-purpose humanoid platforms also target warehouses, sorting, and material movement, so deployment exposure is broader than category labels imply.
The absence of a qualifying Actuation Component Supplier is analytically useful. Investors appear more willing to fund cross-robotics component suppliers or vertically integrated humanoid OEMs than humanoid-only actuator businesses.
The same discipline applies to robot foundation models. A model company serving cars, quadrupeds, arms, and humanoids should not have its entire financing counted as humanoid robotics capital.
Strict pure-play screening therefore has substantial impact on market size. Including FieldAI, Physical Intelligence, Skild AI, LimX Dynamics, generic dexterous-hand suppliers, or transitioning cobot companies would materially inflate the total.
Asia-Pacific wins on company density, while North America wins on capital density. These are different competitive advantages and should not be reduced to a single regional funding ranking.
China's financing pattern favors a deeper bench of companies repeatedly raising roughly nine-figure rounds. That creates greater platform diversity, but it may also increase eventual consolidation pressure.
North America instead concentrates capital around a much smaller number of perceived leaders. This makes regional totals especially sensitive to the financing decisions of Figure and Apptronik.
Europe appears differentiated rather than broad. Flexion focuses on humanoid intelligence, while Generative Bionics and Humanoid emphasize industrial systems, but the region operates with materially less growth capital.
Strategic investors deserve more weight than passive capital alone. Automakers, logistics operators, chip companies, industrial suppliers, and government funds can provide customers, factories, components, and deployment environments alongside financing.
A financing backed by a plausible manufacturer or end user can therefore contain more commercialization information than an equally large round led only by financial investors. Investor identity should be interpreted alongside round size.
Government-linked financing also requires careful interpretation. It validates access to strategic capital, but it is not the same signal as recurring unsubsidized robot orders and sustained field utilization.
The most useful future screening rule is to combine follow-on size, financing cadence, industrial investor participation, and concrete deployment evidence. Together, those indicators separate scale-building progress from valuation headlines more effectively than funding size alone.
The larger implication is that the competitive bottleneck is shifting from building a humanoid prototype toward manufacturing, reliability, data acquisition, and deployment economics. The funding amounts increasingly resemble factory and fleet capital rather than laboratory research budgets.
Figure (Series C), Apptronik (Series A-X extension), XPENG Robotics (first external financing), XPENG regulatory filing (robotics financing), ROBOTERA (May 2026 financing), ROBOTERA (March 2026 financing), Galbot (December 2025 financing), Caixin Global (Galbot March 2026), Caixin Global (Galaxea AI), Caixin Global (X-Humanoid), Caixin Global (Noetix Robotics Series B), Caixin Global (X Square Robot), Caixin Global (ROBOTERA), Bloomberg (Leju Robotics), TechCrunch (Sunday Robotics), Flexion ($50M Series A), Tether (Generative Bionics), Humanoid ($152M Series A), Booster Robotics (April 2026 financing), TechNode (Noetix Robotics)
Related blog posts
- What are the key fundraising trends in the humanoid robotics market?
- The startups that have raised the most funding in the humanoid robotics market
- How funding activity has changed in the humanoid robotics market
- The latest funding news in the humanoid robotics market
- A full list of funding deals in the humanoid robotics market
Who is the author of this content?
NEW MARKET PITCH TEAM
We track new markets so founders and investors can move fasterWe build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.